Tae Hwa Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Tae Hwa Lee has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Dae-Hee Lee
Department of Neurosurgery, University of Virginia, School of Medicine, USA
2 shared publicationsDong-Wook Kim
Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, USA
2 shared publicationsSung Han Kim
Department of Obstetrics and Gynecology, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Korea
2 shared publicationsWon Gyu Kim
Department of Obstetrics and Gynecology, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Korea
2 shared publications- Byung Su Kwon
Department of Obstetrics & Gynecology, School of Medicine, Kyung Hee University Medical Center, Kyung Hee University, Seoul, Republic of Korea
1 shared publication Chang Sup Lee
1 shared publication
Latest Publications
- Open Access
- 8 March 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (10) , e37426
Comparison of survival outcome of open, total laparoscopic, and laparoscopy-assisted radical vaginal hysterectomy for stage IB2 cervical cancer patients: A multicenter retrospective study
The aim of this study was to compare survival outcomes of 3 different radical hysterectomy (RH) types, namely total abdominal radical hysterectomy (TARH), total laparoscopic radical hysterectomy (TLRH), and laparoscopy-assisted radical vaginal hysterectomy (LARVH), in patients with FIGO stage IB2 cervical cancer. We retrospectively identified a cohort of patients who underwent RH for cervical cancer between 2010 and 2017. Patients with stage IB2 cervical cancer were included and were classified into TARH, TLRH, and LARVH treatment groups. Survival outcomes were estimated by the Kaplan–Meier method and compared with the log-rank test. Cox proportional hazards models were fit to estimate the independent association of RH technique with outcome. 194 patients were included in this study: 79 patients in the TARH group, 55 in the TLRH group, and 60 in the LARVH group. No significant differences were found in clinicopathological characteristics between the 3 RH groups. On comparing survival outcomes with TARH, both TLRH and LARVH showed no significant difference in terms of 5-year overall survival (TARH vs TLRH, P = .121 and TARH vs LARVH, P = .436). Conversely, compared to the TARH group, 5-year progression-free survival (PFS) was significantly worse in the TLRH group (P = .034) but not in the LARVH group (P = .288). Multivariate analysis showed that TLRH surgical approach (hazard ratio, 3.232; 95% confidence interval, 1.238–8.438; P = .017) was an independent prognostic factor for PFS in patients with IB2 cervical cancer. Our study suggests that in patients with FIGO stage IB2 cervical cancer, among the minimally invasive RH approaches, TLRH and LARVH, only TLRH approach was associated with worse PFS when compared with the TARH approach.
- 8 March 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (10) , e37426
Open AccessComparison of survival outcome of open, total laparoscopic, and laparoscopy-assisted radical vaginal hysterectomy for stage IB2 cervical cancer patients: A multicenter retrospective study
The aim of this study was to compare survival outcomes of 3 different radical hysterectomy (RH) types, namely total abdominal radical hysterectomy (TARH), total laparoscopic radical hysterectomy (TLRH), and laparoscopy-assisted radical vaginal hysterectomy (LARVH), in patients with FIGO stage IB2 cervical cancer. We retrospectively identified a cohort of patients who underwent RH for cervical cancer between 2010 and 2017. Patients with stage IB2 cervical cancer were included and were classified into TARH, TLRH, and LARVH treatment groups. Survival outcomes were estimated by the Kaplan–Meier method and compared with the log-rank test. Cox proportional hazards models were fit to estimate the independent association of RH technique with outcome. 194 patients were included in this study: 79 patients in the TARH group, 55 in the TLRH group, and 60 in the LARVH group. No significant differences were found in clinicopathological characteristics between the 3 RH groups. On comparing survival outcomes with TARH, both TLRH and LARVH showed no significant difference in terms of 5-year overall survival (TARH vs TLRH, P = .121 and TARH vs LARVH, P = .436). Conversely, compared to the TARH group, 5-year progression-free survival (PFS) was significantly worse in the TLRH group (P = .034) but not in the LARVH group (P = .288). Multivariate analysis showed that TLRH surgical approach (hazard ratio, 3.232; 95% confidence interval, 1.238–8.438; P = .017) was an independent prognostic factor for PFS in patients with IB2 cervical cancer. Our study suggests that in patients with FIGO stage IB2 cervical cancer, among the minimally invasive RH approaches, TLRH and LARVH, only TLRH approach was associated with worse PFS when compared with the TARH approach.
- Open Access
- 31 December 2019
- Published by Kosin University College of Medicine in Kosin Medical Journal
- Vol. 34 (2) , 106-116
Genipin Inhibits Hypoxia-Induced Accumulation of HIF-1α and VEGF Expressions in Human Cervical Carcinoma Cells
Jin CE, et al. Kosin Med J. 2019 Dec;34(2):106-116. https://doi.org/10.7180/kmj.2019.34.2.106
- 31 December 2019
- Published by Kosin University College of Medicine in Kosin Medical Journal
- Vol. 34 (2) , 106-116
Open AccessGenipin Inhibits Hypoxia-Induced Accumulation of HIF-1α and VEGF Expressions in Human Cervical Carcinoma Cells
Jin CE, et al. Kosin Med J. 2019 Dec;34(2):106-116. https://doi.org/10.7180/kmj.2019.34.2.106
- Open Access
- 1 January 2015
- Published by Korean Society of Obstetrics and Gynecology in Obstetrics & Gynecology Science
- Vol. 58 (1) , 32-39
Krukenberg tumors of gastric origin versus colorectal origin
Jeung YJ, et al. Obstet Gynecol Sci. 2015 Jan;58(1):32-39. http://dx.doi.org/10.5468/ogs.2015.58.1.32
- 1 January 2015
- Published by Korean Society of Obstetrics and Gynecology in Obstetrics & Gynecology Science
- Vol. 58 (1) , 32-39
Open AccessKrukenberg tumors of gastric origin versus colorectal origin
Jeung YJ, et al. Obstet Gynecol Sci. 2015 Jan;58(1):32-39. http://dx.doi.org/10.5468/ogs.2015.58.1.32
- 1 April 2014
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 446 (4) , 815-821
Phenethyl isothiocyanate sensitizes glioma cells to TRAIL-induced apoptosis
- 1 April 2014
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 446 (4) , 815-821
Phenethyl isothiocyanate sensitizes glioma cells to TRAIL-induced apoptosis
- 1 January 2014
- Published by Wolters Kluwer Health in Anti-Cancer Drugs
- Vol. 25 (1) , 44-52
Digitoxin sensitizes glioma cells to TRAIL-mediated apoptosis by upregulation of death receptor 5 and downregulation of survivin
Glioblastoma multiforme is the most lethal and aggressive astrocytoma among primary brain tumors in adults. However, most glioblastoma cells have been reported to be resistant to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. Here, we have shown that digitoxin (DT), a clinically approved cardiac glycoside for heart failure, can induce TRAIL-mediated apoptosis of glioblastoma cells. DT in noncytotoxic doses (20 nmol/l) can increase TRAIL-induced apoptosis in TRAIL-resistant U87MG glioblastoma cells. Treatment with DT led to apoptosis and a robust reduction in the levels of the antiapoptotic protein survivin by inducing its proteasomal degradation; however, it did not affect the levels of many other apoptosis regulators. Moreover, silencing survivin with small interfering RNAs sensitized glioma cells to TRAIL-induced apoptosis, underscoring the functional role of survivin depletion in the TRAIL-sensitizing actions of DT. We demonstrate that inactivation of survivin and death receptor 5 expression by DT is sufficient to restore TRAIL sensitivity in resistant glioma cells. Our results suggest that combining DT with TRAIL treatments may be useful in the treatment of TRAIL-resistant glioma cells.
- 1 January 2014
- Published by Wolters Kluwer Health in Anti-Cancer Drugs
- Vol. 25 (1) , 44-52
Digitoxin sensitizes glioma cells to TRAIL-mediated apoptosis by upregulation of death receptor 5 and downregulation of survivin
Glioblastoma multiforme is the most lethal and aggressive astrocytoma among primary brain tumors in adults. However, most glioblastoma cells have been reported to be resistant to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. Here, we have shown that digitoxin (DT), a clinically approved cardiac glycoside for heart failure, can induce TRAIL-mediated apoptosis of glioblastoma cells. DT in noncytotoxic doses (20 nmol/l) can increase TRAIL-induced apoptosis in TRAIL-resistant U87MG glioblastoma cells. Treatment with DT led to apoptosis and a robust reduction in the levels of the antiapoptotic protein survivin by inducing its proteasomal degradation; however, it did not affect the levels of many other apoptosis regulators. Moreover, silencing survivin with small interfering RNAs sensitized glioma cells to TRAIL-induced apoptosis, underscoring the functional role of survivin depletion in the TRAIL-sensitizing actions of DT. We demonstrate that inactivation of survivin and death receptor 5 expression by DT is sufficient to restore TRAIL sensitivity in resistant glioma cells. Our results suggest that combining DT with TRAIL treatments may be useful in the treatment of TRAIL-resistant glioma cells.
- Open Access
- 1 January 2012
- Published by Korean Society of Obstetrics and Gynecology in Korean Journal of Obstetrics & Gynecology
- Vol. 55 (8) , 596-600
Postirradiation malignant fibrous histiocytoma of the vulva and vagina following recurrent cervix cancer
Yun HG, et al. Korean J Obstet Gynecol. 2012 Aug;55(8):596-600. http://dx.doi.org/10.5468/KJOG.2012.55.8.596
- 1 January 2012
- Published by Korean Society of Obstetrics and Gynecology in Korean Journal of Obstetrics & Gynecology
- Vol. 55 (8) , 596-600
Open AccessPostirradiation malignant fibrous histiocytoma of the vulva and vagina following recurrent cervix cancer
Yun HG, et al. Korean J Obstet Gynecol. 2012 Aug;55(8):596-600. http://dx.doi.org/10.5468/KJOG.2012.55.8.596
- Open Access
- 1 January 2011
- Published by Korean Society of Obstetrics and Gynecology in Korean Journal of Obstetrics & Gynecology
- Vol. 54 (4)
Malignant pericardial effusion in carcinoma of the uterine cervix
- 1 January 2011
- Published by Korean Society of Obstetrics and Gynecology in Korean Journal of Obstetrics & Gynecology
- Vol. 54 (4)
Open AccessMalignant pericardial effusion in carcinoma of the uterine cervix